Skip To Main Content
Ciaran Ryan on Muck Rack

Ciaran Ryan

Verified
South Africa
As seen in: Moneyweb, Moneyweb Crypto, The Writer's Room, LinkedIn, MSN South Africa, Flipboard, News24, News24 Business, Independent Online, Sunday Times, The South African, TimesLIVE, AllAfrica and
Editor Moneyweb Crypto, also covering mining, local government and some touching human stories.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ciaran

Contact Ciaran, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Guggenheim affiliate buys debt tied to asset management arm as loan price rebounds

|
By Ciaran Ryan Verified
| Traders Union
Trading in debt linked to Guggenheim Partners' asset management business is drawing close scrutiny as investors look for one of the few market signals tied to Mark Walter's privately held firm. A Guggenheim affiliate is now buying portions of the loan, helping lift the price after it traded at distressed levels last week.
Open in Who Shared View Duplicates (2) Issue with article?

Walmart agrees to pay $50 million in U.S. opioid prescription settlement

|
By Ciaran Ryan Verified
| Traders Union
Federal authorities are resolving a long-running case over how controlled substances were dispensed at Walmart pharmacies across the U.S. The settlement includes operational changes for future opioid and controlled-substance dispensing, alongside the $50 million payment. Highlights Walmart agrees to pay $50 million to resolve allegations it illegally filled thousands of invalid opioid prescriptions since June 26, 2013.
Open in Who Shared Issue with article?

INJ drops as sellers dominate intraday trend

|
By Ciaran Ryan Verified
| Traders Union
Injective (INJ) is trading at $5.09, marking a decline of 7.02% on the day. The price sits below its key short- and medium-term moving averages but remains above its long-term average, highlighting a potential divergence in momentum across timeframes.
Open in Who Shared Issue with article?
See all 14,542 licensed articles (14,547 Total)